HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elias Toubi Selected Research

Semaphorin-3A

1/2019Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.
3/2018Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.
1/2015The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).
8/2014Semaphorins: their dual role in regulating immune-mediated diseases.
6/2014A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
1/2014The role of B regulatory cells and Semaphorin3A in atopic diseases.
6/2012Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elias Toubi Research Topics

Disease

11Chronic Urticaria
11/2021 - 01/2005
10Autoimmune Diseases (Autoimmune Disease)
10/2018 - 04/2004
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2019 - 04/2002
7Infections
01/2017 - 10/2004
6Hereditary Angioedemas
03/2022 - 08/2010
6Urticaria (Hives)
12/2019 - 01/2005
6Inflammation (Inflammations)
01/2019 - 10/2007
5Asthma (Bronchial Asthma)
11/2021 - 01/2014
3Rheumatoid Arthritis
11/2020 - 04/2002
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2013 - 06/2004
2Neoplasms (Cancer)
02/2017 - 08/2014
2Angioedema
01/2015 - 08/2010
2Lupus Nephritis
06/2014 - 09/2004
2Allergic Rhinitis
01/2014 - 02/2008
2Thrombocytopenia (Thrombopenia)
01/2013 - 11/2012
2Agammaglobulinemia (Hypogammaglobulinemia)
11/2012 - 12/2005
2Chronic Hepatitis C
10/2007 - 10/2003
1Systemic Vasculitis
10/2018
1Anaphylaxis (Anaphylactic Shock)
02/2017
1Communicable Diseases (Infectious Diseases)
01/2017
1Immunoglobulin G4-Related Disease
08/2015
1Central Nervous System Lupus Vasculitis
07/2015
1Fibromyalgia (Fibrositis)
07/2015
1Rheumatic Diseases (Rheumatism)
07/2015
1Tuberculosis (Tuberculoses)
04/2015
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2015
1Ulcerative Colitis
01/2015
1Chest Pain (Chest Pains)
01/2015
1Crohn Disease (Crohn's Disease)
01/2015
1Cardiac Arrhythmias (Arrythmia)
01/2015
1Neoplasm Metastasis (Metastasis)
08/2014
1Cogan Syndrome
05/2014
1Atopic Dermatitis (Atopic Eczema)
01/2014
1Thrombocytopenic Purpura (Thrombopenic Purpura)
01/2013
1Common Variable Immunodeficiency
11/2012
1Multiple Sclerosis
10/2012
1Experimental Arthritis
06/2012
1Sepsis (Septicemia)
01/2009
1Airway Obstruction (Choking)
02/2008
1Systemic Scleroderma (Systemic Sclerosis)
01/2008
1Liver Diseases (Liver Disease)
10/2007

Drug/Important Bio-Agent (IBA)

7Semaphorin-3AIBA
01/2019 - 06/2012
7AntibodiesIBA
05/2014 - 05/2004
4Immunoglobulin E (IgE)IBA
11/2021 - 01/2010
4Immunoglobulin G (IgG)IBA
12/2019 - 08/2009
4AutoantibodiesIBA
12/2019 - 06/2007
4Adrenal Cortex Hormones (Corticosteroids)IBA
02/2008 - 06/2004
3Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2015
3CytokinesIBA
11/2020 - 10/2003
3Toll-Like Receptors (Toll-Like Receptor)IBA
03/2019 - 04/2004
3Semaphorins (Semaphorin)IBA
01/2019 - 08/2014
3icatibantIBA
04/2018 - 08/2010
3Omalizumab (Xolair)FDA Link
11/2017 - 08/2014
3Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2017 - 06/2006
3Histamine Antagonists (Antihistamines)IBA
02/2017 - 01/2005
3Intravenous Immunoglobulins (IVIG)FDA Link
10/2007 - 04/2004
2AntigensIBA
02/2017 - 09/2009
2Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 01/2009
2Complement System Proteins (Complement)IBA
08/2015 - 06/2014
2anti-dsDNA autoantibodyIBA
06/2014 - 08/2009
2Inosine Triphosphate (ITP)IBA
01/2013 - 11/2012
2Immunoglobulin M (IgM)IBA
11/2012 - 08/2009
2Pharmaceutical PreparationsIBA
10/2012 - 04/2002
2Antinuclear AntibodiesIBA
06/2012 - 06/2007
2C-Reactive ProteinIBA
08/2009 - 10/2007
2Antiviral Agents (Antivirals)IBA
10/2004 - 10/2003
1Interleukin-17 (Interleukin 17)IBA
01/2020
1anti-IgE antibodiesIBA
12/2019
1Fibrinogen (Factor I)FDA Link
10/2018
1Thromboplastin (Tissue Factor)IBA
10/2018
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2018
1Factor XIIa (Coagulation Factor XIIa)IBA
10/2018
1Hemostatics (Antihemorrhagics)IBA
10/2018
1montelukast (Singulair)FDA Link
02/2017
1CD100 antigenIBA
02/2017
1belimumabIBA
01/2017
1Histamine (Histamine Dihydrochloride)FDA Link
01/2016
1GlucocorticoidsIBA
08/2015
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2015
1Interferon-gamma (Interferon, gamma)IBA
04/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Interleukin-10 (Interleukin 10)IBA
06/2014
1Peptides (Polypeptides)IBA
10/2013
1Immunomodulating AgentsIBA
06/2013
1Rituximab (Mabthera)FDA Link
11/2012
1laquinimodIBA
10/2012
1Neuropilin-1IBA
06/2012
1B-Cell Activating FactorIBA
06/2012
1Neutralizing AntibodiesIBA
01/2011
1VaccinesIBA
10/2010
1Tranexamic Acid (AMCA)FDA Link
08/2010
1Bradykinin Receptor AntagonistsIBA
08/2010
1ChromatinIBA
09/2009
1Biological ProductsIBA
09/2009
1Immunoglobulin A (IgA)IBA
08/2009
1Rheumatoid FactorIBA
08/2009
1Budesonide (Pulmicort)FDA LinkGeneric
02/2008
1Endothelin-1 (Endothelin 1)IBA
01/2008

Therapy/Procedure

14Therapeutics
03/2022 - 04/2004
1Splenectomy
11/2012